Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TSPO | P30536 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.30 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.30 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.30 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.30 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.30 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.30 |
| ▸ | GPR3 | P46089 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21454231 | 0.96 | KDM4E (0.33) | KDM4ETSHRHSD17B10TSPOPOLB | |
| SCHEMBL21453776 | 0.95 | TSPO (0.34) | TSPO | |
| SCHEMBL21454230 | 0.92 | TSPO (0.38) | KDM4ETSHRHSD17B10TSPOPOLB | |
| SCHEMBL21454246 | 0.91 | TSPO (0.33) | TSPO | |
| SCHEMBL21453775 | 0.91 | TSPO (0.34) | TSPO | |
| SCHEMBL21454229 | 0.88 | TSPO (0.38) | KDM4ETSHRHSD17B10TSPOPOLB | |
| SCHEMBL21454105 | 0.86 | KDM4E (0.36) | KDM4ETSPO | |
| SCHEMBL23288142 | 0.86 | APP (0.33) | — | |
| SCHEMBL21453491 | 0.85 | — | — | |
| SCHEMBL21453490 | 0.84 | KDM4E (0.30) | KDM4EPOLBMEN1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11038121-B2 | 9 membered ring carbazole compounds | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2021-06-15 | — | — | US | disclosed |
| US-20190312214-A1 | 9 MEMBERED RING CARBAZOLE COMPOUNDS | BEIJING SUMMER SPROUT TECHNOLOGY CO., LTD (CN) | 2019-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11038121-B2 | 9 membered ring carbazole compounds | SLC25A21, OCIAD2, OXA1L | KDM4E 3723/4885TSHR 4332/4885HSD17B10 1511/4885 |
| US-20190312214-A1 | 9 MEMBERED RING CARBAZOLE COMPOUNDS | SLC25A21, OCIAD2, OXA1L | KDM4E 3723/4885TSHR 4332/4885HSD17B10 1511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.